Increased homologous integration frequency in Yarrowia lipolytica strains defective in non-homologous end-joining

Curr Genet. 2013 May;59(1-2):63-72. doi: 10.1007/s00294-013-0389-7. Epub 2013 Feb 20.

Abstract

The ascomycetous yeast Yarrowia lipolytica has been established as model system for studies of several research topics as well as for biotechnological processes in the last two decades. However, frequency of heterologous recombination is high in this yeast species, and so knockouts of genes are laborious to achieve. Therefore, the aim of this study was to check whether a reduction of non-homologous end-joining (NHEJ) of double strand breaks (DSB) results in a strong increase of proportion of homologous recombinants. The Ku70-Ku80 heterodimer is known as an essential protein complex of the NHEJ. We show that deletion of YlKU70 and/or YlKU80 results in an increase of the rate of transformants with homologous recombination (HR) up to 85 % in each case. However, it never reaches near 100 % of HR in any case as described for some other yeast. Furthermore, we demonstrated that growth of Δylku strains was similar to that of the wild-type strain. In addition, no differences were detected between the Δylku strains and the parent strain in respect to sensitivity to the mutagenic agent EMS as well as to the antibiotics hygromycin, bleomycin and nourseothricin. However, Δylku70 and Δylku80 strain showed a slightly higher sensitivity against UV rays. Thus, the new constructed Δylku strains are attractive recipient strains for homologous integration of DNA fragments and a valuable tool for directed knockouts of genes. Nevertheless, our data suggest the existence of another system of non-homologous recombination what may be subject of further investigation.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • DNA End-Joining Repair / genetics*
  • Gene Deletion
  • Homologous Recombination / genetics*
  • Microbial Sensitivity Tests
  • Mutagens / pharmacology
  • Mutation
  • Yarrowia / classification
  • Yarrowia / drug effects
  • Yarrowia / genetics*

Substances

  • Anti-Bacterial Agents
  • Mutagens